McKesson (NYSE:MCK) Updates FY25 Earnings Guidance

McKesson (NYSE:MCK) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $31.25-$32.05 for the period, compared to the consensus estimate of $31.09. The company issued revenue guidance of $355.35-$361.53 billion, compared to the consensus revenue estimate of $341.05 billion.

Wall Street Analysts Forecast Growth

MCK has been the topic of several recent analyst reports. Leerink Partnrs reissued an outperform rating on shares of McKesson in a research note on Monday, February 26th. Morgan Stanley upped their price target on shares of McKesson from $522.00 to $548.00 and gave the stock an overweight rating in a research report on Monday, April 15th. Citigroup lifted their price target on shares of McKesson from $575.00 to $620.00 and gave the company a buy rating in a report on Tuesday, April 30th. Mizuho upped their price objective on McKesson from $450.00 to $505.00 and gave the stock a neutral rating in a report on Friday, February 9th. Finally, UBS Group lifted their price target on shares of McKesson from $575.00 to $620.00 and gave the company a buy rating in a research report on Wednesday, March 6th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of Moderate Buy and an average target price of $536.71.

McKesson Stock Performance

Shares of NYSE MCK traded up $11.12 during midday trading on Tuesday, hitting $544.53. The company’s stock had a trading volume of 983,843 shares, compared to its average volume of 705,665. The firm has a market cap of $71.56 billion, a P/E ratio of 24.67, a P/E/G ratio of 1.41 and a beta of 0.45. McKesson has a 1-year low of $364.08 and a 1-year high of $546.63. The firm’s fifty day moving average price is $531.17 and its 200-day moving average price is $493.81.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, topping analysts’ consensus estimates of $7.05 by $0.69. The business had revenue of $80.90 billion for the quarter, compared to analysts’ expectations of $77.93 billion. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The business’s quarterly revenue was up 14.8% on a year-over-year basis. During the same period in the prior year, the firm earned $6.90 EPS. As a group, research analysts predict that McKesson will post 27.59 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be given a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a yield of 0.46%. The ex-dividend date of this dividend is Friday, May 31st. McKesson’s payout ratio is 11.24%.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 186 shares of the stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the transaction, the chief executive officer now directly owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the sale, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The disclosure for this sale can be found here. Company insiders own 0.21% of the company’s stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.